Investor Call Recording Q4 & FY26
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Camlin Fine Sciences Ltd disclosed the availability of an audio recording from its investor conference call held on May 26, 2026, covering Q4 and FY26 audited financial results (standalone and consolidated). The call was attended by Chairman & MD Mr. Ashish Dandekar, MD Mr. Nirmal Momaya, and CFO Mr. Santosh Parab. The company clarified that discussions were based solely on publicly available information and that no unpublished price sensitive information (UPSI) was shared during the interaction. This is a routine regulatory compliance filing under SEBI LODR Regulation 30(6) to announce the availability of the recording on the company's investor relations website.
This filing is procedural in nature — it announces the existence of an earnings call recording but does not itself contain any new financial guidance, targets, or strategic disclosures. Investors should access the actual recording on the company's website for detailed management commentary.